Jump to content

Drilldown: Medicines

Nav

Choose a table:

Medicines (732)

Medicines > generic

: 2-FDCK

or 2-FMA

or Bromazolam

Use the filters below to narrow your results.

None (2) · (none, never marketed) (1)

Amphetamine (1) · Designer benzodiazepine (1) · Dissociative (1) · Research material (3) · Sedative-Hypnotic (1) · Stimulant (1) · Triazolobenzodiazepine (1)

Monoamine releasing agent (1) · NMDA antagonist; fluorinated ketamine analogue (1) · Positive allosteric modulator of the GABA<sub>A</sub> receptor at the benzodiazepine binding site; increases frequency of Cl<sup>−</sup> channel opening, producing anxiolytic, sedative, hypnotic, anticonvulsant, and skeletal-muscle relaxant effects. (1)

None (2) · No approved medical problem. Encountered as a designer/research benzodiazepine and, increasingly, as an adulterant in illicit opioid supplies. (1)

None (2) · No medical dose. Active recreational doses reported in the 0.5–1.5 mg range (similar potency to alprazolam). (1)

None (2) · Illicit tablets ("bars"), powders, blotter, occasionally solutions. No pharmaceutical product exists. (1)

None (2) · N/A (never approved) (1)

None (2) · intranasal; rectal and IV reported. (1) · Oral (1) · sublingual (1)

None (2) · ~20–40 min PO; faster sublingual/intranasal. (1)

None (2) · 6–10 h subjective; full pharmacologic effect considerably longer. (1)

None (2) · Estimated ~12–17 h (some sources cite up to ~21 h); active metabolites prolong effect. (1)

None (2) · Not formally characterized in humans. (1)

None (2) · Avoid. Benzodiazepines are associated with neonatal sedation, floppy-infant syndrome, and withdrawal; teratogenic signal weak but non-zero. Designer benzo with no safety data, assume worst-case. (1)

None (3)

Showing below up to 3 results in range #1 to #3.

2

2-FDCK

2-FMA

B

Bromazolam

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"